(18)F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors

Aim. (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) is a powerful tool for staging and defining “good responders” to chemotherapy in tumor setting. Gastrointestinal stromal tumors (GISTs) are sarcoma involving gastrointestinal tract and may require a chemotherapy including ima...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanelli, Antonella, Treglia, Giorgio, Mirk, Paoletta, Muoio, Barbara, Giordano, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168535/
https://www.ncbi.nlm.nih.gov/pubmed/21991530
http://dx.doi.org/10.5402/2011/824892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168535/
https://www.ncbi.nlm.nih.gov/pubmed/21991530
http://dx.doi.org/10.5402/2011/824892

Ejemplares similares